Whitehawk Therapeutics (WHWK) Total Debt (2020 - 2021)
Whitehawk Therapeutics' (WHWK) quarterly Total Debt came in at $6.0 million in Q4 2021, down 57.98% year-on-year from $14.3 million in Q4 2020, and up 4.08% on a QoQ basis from $5.8 million in Q3 2021.
Whitehawk Therapeutics (WHWK) Total Debt (2020 - 2021) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 2 years of Total Debt data on file, last reported at $6.0 million in Q4 2021.
- On a quarterly basis, Total Debt fell 57.98% year-over-year to $6.0 million in Q4 2021; TTM through Dec 2021 was $6.0 million, a 57.98% decrease from a year earlier, with the FY2021 full-year figure at $6.0 million, down 57.98% from the prior year.
- Total Debt for Q4 2021 stood at $6.0 million, up from $5.8 million in the prior quarter.
- Over the last five years, Total Debt for WHWK reached as high as $14.3 million in Q4 2020 and fell as low as $5.8 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 959.06 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Whitehawk Therapeutics | 34.18 Mn | 34.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 6.02 Mn |
| Sep 30, 2021 | 5.78 Mn |
| Dec 31, 2020 | 14.31 Mn |